Squarepoint’s NovoCure NVCR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-53,045
Closed -$686K 4738
2025
Q4
$686K Sell
53,045
-29,122
-35% -$374K ﹤0.01% 2940
2025
Q3
$1.06M Sell
82,167
-28,437
-26% -$380K ﹤0.01% 2642
2025
Q2
$1.97M Buy
110,604
+77,685
+236% +$1.35M ﹤0.01% 2118
2025
Q1
$587K Sell
32,919
-677
-2% -$15.4K ﹤0.01% 3145
2024
Q4
$1M Buy
+33,596
New +$711K ﹤0.01% 3067
2024
Q2
Sell
-331,184
Closed -$5.18M 4470
2024
Q1
$5.18M Buy
331,184
+260,460
+368% +$3.83M 0.01% 1416
2023
Q4
$1.06M Buy
70,724
+9,260
+15% +$124K ﹤0.01% 2481
2023
Q3
$993K Buy
61,464
+51,456
+514% +$1.48M ﹤0.01% 2324
2023
Q2
$415K Sell
10,008
-84,708
-89% -$5.26M ﹤0.01% 2742
2023
Q1
$5.7M Buy
+94,716
New +$7.57M 0.02% 810
2022
Q4
Sell
-20,286
Closed -$1.54M 3491
2022
Q3
$1.54M Buy
+20,286
New +$1.58M 0.01% 1490
2022
Q2
Sell
-7,344
Closed -$608K 3223
2022
Q1
$608K Sell
7,344
-32,578
-82% -$2.4M ﹤0.01% 1891
2021
Q4
$3M Sell
39,922
-93,344
-70% -$9.37M 0.01% 1029
2021
Q3
$15.5M Buy
133,266
+60,420
+83% +$9.14M 0.04% 367
2021
Q2
$16.2M Buy
72,846
+31,899
+78% +$6.21M 0.06% 296
2021
Q1
$5.41M Buy
40,947
+17,136
+72% +$2.71M 0.03% 594
2020
Q4
$4.12M Buy
23,811
+13,037
+121% +$1.78M 0.03% 567
2020
Q3
$1.2M Sell
10,774
-175,221
-94% -$14M 0.02% 897
2020
Q2
$11M Buy
185,995
+176,738
+1,909% +$11.6M 0.18% 144
2020
Q1
$623K Sell
9,257
-23,738
-72% -$1.88M 0.02% 922
2019
Q4
$2.78M Buy
32,995
+22,399
+211% +$1.81M 0.02% 718
2019
Q3
$792K Sell
10,596
-50,004
-83% -$4M 0.01% 1382
2019
Q2
$3.83M Buy
60,600
+23,150
+62% +$1.17M 0.04% 540
2019
Q1
$1.8M Buy
37,450
+8,396
+29% +$404K 0.02% 820
2018
Q4
$973K Sell
29,054
-745
-3% -$27.2K 0.01% 931
2018
Q3
$1.56M Buy
29,799
+2,026
+7% +$80.6K 0.02% 810
2018
Q2
$869K Sell
27,773
-18,575
-40% -$517K 0.01% 941
2018
Q1
$1.01M Buy
46,348
+30,417
+191% +$654K 0.02% 808
2017
Q4
$322K Buy
+15,931
New +$307K 0.01% 1455

Other funds holding NVCR